White Paper: Looking Ahead: Dermatology Clinical Trial Landscape in 2023

White Paper: Looking Ahead: Dermatology Clinical Trial Landscape in 2023

The global market for dermatology drugs is projected to grow at a CAGR of 11.22% from 2022 to 2027 to reach US$47.9 billion by 2027. The primary factors driving growth are the increasing prevalence of dermatological conditions and the rise of R&D in healthcare. Download Vial’s white paper to learn more about the dermatology clinical trial landscape in 2023!

This white paper will cover:

Growth in the dermatology drug market
Projections for dermatology treatment spending
Challenges and opportunities in tele-dermatology

More Resources

Whitepaper

Precision Medicine in Cardiology

Whitepaper

Case Study: Addressing Diversity Challenges in Subject Recruitment for Dermatology Trials

Whitepaper

Looking Ahead: Neurology Clinical Trial Landscape in 2023

Connect with us.

Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.

Name(Required)

Work email(Required)

Phone

Company(Required)

Which best describes you?(Required)

Message

By submitting, you are agreeing to our terms and privacy policy

Email

This field is for validation purposes and should be left unchanged.